Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures.

Verroken, A; Defourny, L; le Polain de Waroux, O; Belkhir, L; Laterre, PF; Delmée, M; Glupczynski, Y; (2016) Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures. PloS one, 11 (5). e0156299. ISSN 1932-6203 DOI: https://doi.org/10.1371/journal.pone.0156299

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1371/journal.pone.0156299

Abstract

Share

Download

Filename: pone.0156299.PMC4881997.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar